These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38940542)

  • 41. Patient-Derived Antibody Data Yields Development of Broadly Cross-Protective Monoclonal Antibody against ST258 Carbapenem-Resistant
    Banerjee K; Motley MP; Boniche-Alfaro C; Bhattacharya S; Shah R; Ardizzone A; Fries BC
    Microbiol Spectr; 2022 Aug; 10(4):e0176022. PubMed ID: 35862974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
    Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Murine monoclonal antibodies to Klebsiella pneumoniae protect against lethal endotoxemia and experimental infection with capsulated K. pneumoniae.
    Mandine E; Salles MF; Zalisz R; Guenounou M; Smets P
    Infect Immun; 1990 Sep; 58(9):2828-33. PubMed ID: 1696932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of adhesion of Escherichia coli k88ac fimbria to its receptor, intestinal mucin-type glycoproteins, by a monoclonal antibody directed against a variable domain of the fimbria.
    Sun R; Anderson TJ; Erickson AK; Nelson EA; Francis DH
    Infect Immun; 2000 Jun; 68(6):3509-15. PubMed ID: 10816505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphorylated OmpR Is Required for Type 3 Fimbriae Expression in
    Lin TH; Chen Y; Kuo JT; Lai YC; Wu CC; Huang CF; Lin CT
    Front Microbiol; 2018; 9():2405. PubMed ID: 30369914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Klebsiella pneumoniae type 3 fimbriae agglutinate yeast in a mannose-resistant manner.
    Stahlhut SG; Struve C; Krogfelt KA
    J Med Microbiol; 2012 Mar; 61(Pt 3):317-322. PubMed ID: 22016558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Investigation of various virulence factors of Klebsiella pneumoniae strains isolated from nosocomial infections].
    Kuş H; Arslan U; Türk Dağı H; Fındık D
    Mikrobiyol Bul; 2017 Oct; 51(4):329-339. PubMed ID: 29153063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of the stress-responsive two-component system CpxAR in regulating fimbriae expression in Klebsiella pneumoniae CG43.
    Kuo CH; Lin WF; Liu CJ; Wang ZC; Liu TY; Peng HL
    J Microbiol Immunol Infect; 2023 Jun; 56(3):464-476. PubMed ID: 36898943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Signature-tagged mutagenesis of Klebsiella pneumoniae to identify genes that influence biofilm formation on extracellular matrix material.
    Boddicker JD; Anderson RA; Jagnow J; Clegg S
    Infect Immun; 2006 Aug; 74(8):4590-7. PubMed ID: 16861646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.
    Clements A; Jenney AW; Farn JL; Brown LE; Deliyannis G; Hartland EL; Pearse MJ; Maloney MB; Wesselingh SL; Wijburg OL; Strugnell RA
    Vaccine; 2008 Oct; 26(44):5649-53. PubMed ID: 18725260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Importance of antiserum and phagocytic cells in the protection of mice against infection by Klebsiella pneumoniae.
    Fukutome T; Mitsuyama M; Takeya K; Nomoto K
    J Gen Microbiol; 1980 Jul; 119(1):225-9. PubMed ID: 6997433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of Novel
    Mulani MS; Kumkar SN; Pardesi KR
    Microbiol Spectr; 2022 Dec; 10(6):e0199422. PubMed ID: 36374021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model.
    Hussein KE; Bahey-El-Din M; Sheweita SA
    Microb Pathog; 2018 Jun; 119():12-18. PubMed ID: 29626658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human monoclonal antibodies specific for capsular polysaccharides of Klebsiella recognize clusters of multiple serotypes.
    Lang AB; Bruderer U; Senyk G; Pitt TL; Larrick JW; Cryz SJ
    J Immunol; 1991 May; 146(9):3160-4. PubMed ID: 2016541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Positive autoregulation of mrkHI by the cyclic di-GMP-dependent MrkH protein in the biofilm regulatory circuit of Klebsiella pneumoniae.
    Tan JW; Wilksch JJ; Hocking DM; Wang N; Srikhanta YN; Tauschek M; Lithgow T; Robins-Browne RM; Yang J; Strugnell RA
    J Bacteriol; 2015 May; 197(9):1659-67. PubMed ID: 25733612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen.
    Rollenske T; Szijarto V; Lukasiewicz J; Guachalla LM; Stojkovic K; Hartl K; Stulik L; Kocher S; Lasitschka F; Al-Saeedi M; Schröder-Braunstein J; von Frankenberg M; Gaebelein G; Hoffmann P; Klein S; Heeg K; Nagy E; Nagy G; Wardemann H
    Nat Immunol; 2018 Jun; 19(6):617-624. PubMed ID: 29760533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD36 Provides Host Protection Against Klebsiella pneumoniae Intrapulmonary Infection by Enhancing Lipopolysaccharide Responsiveness and Macrophage Phagocytosis.
    Olonisakin TF; Li H; Xiong Z; Kochman EJ; Yu M; Qu Y; Hulver M; Kolls JK; St Croix C; Doi Y; Nguyen MH; Shanks RM; Mallampalli RK; Kagan VE; Ray A; Silverstein RL; Ray P; Lee JS
    J Infect Dis; 2016 Dec; 214(12):1865-1875. PubMed ID: 27683817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progress towards the development of Klebsiella vaccines.
    Choi M; Tennant SM; Simon R; Cross AS
    Expert Rev Vaccines; 2019 Jul; 18(7):681-691. PubMed ID: 31250679
    [No Abstract]   [Full Text] [Related]  

  • 59. CRP-Cyclic AMP Regulates the Expression of Type 3 Fimbriae via Cyclic di-GMP in Klebsiella pneumoniae.
    Lin CT; Lin TH; Wu CC; Wan L; Huang CF; Peng HL
    PLoS One; 2016; 11(9):e0162884. PubMed ID: 27631471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Development of Immunological Assays to Evaluate the Level and Function of Antibodies Induced by Klebsiella pneumoniae O-Antigen Vaccines.
    Wagstaffe HR; Johnson M; Osman G; Martin P; Carranza P; Goldblatt D
    mSphere; 2023 Apr; 8(2):e0068022. PubMed ID: 36877023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.